Trial Profile
A retrospective real-world observational study comparing Trulicity with once-daily liraglutide and once-weekly exenatide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2019
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Exenatide; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 May 2019 Results assessing the Adherence and Persistence Among Elderly Patients with T2dm Initiating Dulaglutide vs. Liraglutide or Exenatide Once-Weekly in the US, presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes